Matteo Molica - Dissemin

Language
Login

All papers authored by Matteo Molica

This paper is made freely available by the publisher.

2023 Matteo Molica

ORCID

, Salvatore Perrone

ORCID

, Vincenzo Federico, Caterina Alati, Stefano Molica

ORCID

, Marco Rossi

Venetoclax: A Game Changer in the Treatment of Younger AML Patients?

Download from doi.org

This paper is made freely available by the publisher.

Matteo Molica

ORCID

, Salvatore Perrone

ORCID

, Costanza Andriola, Marco Rossi

ORCID

Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in Progress

Download from doi.org

This paper is made freely available by the publisher.

Matteo Molica

ORCID

, Salvatore Perrone

ORCID

ORCID

Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat FLT3-Mutated AML Patients

Download from doi.org

This paper is made freely available by the publisher.

2022 Matteo Molica

ORCID

, Carla Mazzone, Pasquale Niscola

ORCID

, Ida Carmosino, Ambra Di Veroli, Cinzia De Gregoris, Fabrizio Bonanni, Salvatore Perrone

ORCID

, Natalia Cenfra, Luana Fianchi, Anna Lina Piccioni, Antonio Spadea, Giovanni Luzi, Andrea Mengarelli

ORCID

, Laura Cudillo and 5 other authors

Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience

Download from doi.org

This paper is made freely available by the publisher.

Matteo Molica

ORCID

, Salvatore Perrone

ORCID

, Carla Mazzone, Laura Cesini, Martina Canichella, Paolo de Fabritiis

CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML

Download from doi.org

This paper is made freely available by the publisher.

2018 Giovanni Caocci

ORCID

, Olga Mulas, Mario Annunziata, Luigiana Luciano, Massimiliano Bonifacio, Ester Maria Orlandi, Patrizia Pregno, Sara Galimberti

ORCID

, Antonella Russo Rossi, Elisabetta Abruzzese, Alessandra Iurlo

ORCID

, Bruno Martino, Nicola Sgherza, Gianni Binotto, Fausto Castagnetti and 21 other authors

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis

Download from api.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

2017 Matteo Molica

ORCID

, Martina Canichella, Danilo Alunni Fegatelli, Gioia Colafigli, Fulvio Massaro, Roberto Latagliata

ORCID

, Robin Foà, Massimo Breccia

ORCID

The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials

Upload

Missing publications? Search for publications with a matching author name.